Sinopharm Group Co. Ltd. (HKG: 1099)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
20.85
+0.50 (2.46%)
Oct 10, 2024, 4:08 PM HKT

Sinopharm Group Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Oct '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
65,06663,81761,91452,92658,81884,429
Upgrade
Market Cap Growth
-15.31%3.07%16.98%-10.02%-30.33%-13.46%
Upgrade
Enterprise Value
177,473158,985148,432150,328130,396132,439
Upgrade
Last Close Price
20.8519.5618.3214.9616.1023.47
Upgrade
PE Ratio
6.996.115.924.905.879.99
Upgrade
PS Ratio
0.100.100.100.080.110.18
Upgrade
PB Ratio
0.800.480.500.430.550.98
Upgrade
P/FCF Ratio
3.513.812.915.965.354.55
Upgrade
P/OCF Ratio
3.093.372.614.634.444.02
Upgrade
EV/Sales Ratio
0.280.240.240.240.240.28
Upgrade
EV/EBITDA Ratio
6.245.915.305.355.265.95
Upgrade
EV/EBIT Ratio
7.506.475.775.845.756.51
Upgrade
EV/FCF Ratio
9.589.496.9716.9311.867.14
Upgrade
Debt / Equity Ratio
0.830.610.630.690.760.72
Upgrade
Debt / EBITDA Ratio
3.992.782.602.763.042.60
Upgrade
Debt / FCF Ratio
5.864.853.699.457.403.33
Upgrade
Asset Turnover
1.391.591.581.611.571.68
Upgrade
Inventory Turnover
8.009.068.989.689.289.94
Upgrade
Quick Ratio
1.011.060.991.020.990.94
Upgrade
Current Ratio
1.351.391.361.331.311.29
Upgrade
Return on Equity (ROE)
11.90%13.03%13.68%13.78%14.50%14.63%
Upgrade
Return on Assets (ROA)
3.08%3.73%4.06%4.06%4.11%4.49%
Upgrade
Return on Capital (ROIC)
6.04%7.46%8.18%8.03%8.22%8.89%
Upgrade
Earnings Yield
14.36%15.63%15.57%17.99%14.51%8.28%
Upgrade
FCF Yield
28.61%26.26%34.39%16.78%18.69%21.96%
Upgrade
Dividend Yield
4.59%4.90%5.06%6.16%5.09%2.86%
Upgrade
Payout Ratio
29.57%28.26%27.45%27.75%25.95%28.04%
Upgrade
Buyback Yield / Dilution
0.06%-0.12%-0.30%-4.70%-0.07%
Upgrade
Total Shareholder Return
4.64%4.90%5.18%5.85%0.39%2.79%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.